摘要
目的:探讨穴位埋线结合降糖药对糖尿病患者胰高血糖素样肽-1(GLP-1)水平的影响。方法:将74例糖尿病病患者随机分为降糖药加穴位埋线组、穴位埋线组和降糖药组3组,观察患者的胰高血糖素样肽-1(GLP-1)水平变化。结果:降糖药加穴位埋线组患者的胰高血糖素样肽-1(GLP-1)水平治疗前后对比有统计学意义(P<0.05),且治疗后降糖药加穴位埋线组与穴位埋线组、降糖药组比较差异均有统计学意义(P<0.05)。通过观察对比三组糖尿病患者治疗前后GLP-1水平,评判治疗效果,降糖药加穴位埋线组有效率92.00%,穴位埋线组有效率66.67%,降糖药组有效率80.00%。降糖药加穴位埋线组有效率高于穴位埋线组、降糖药组,且有统计学意义(P<0.05)。结论:穴位埋线结合降糖药对糖尿病具有显著临床疗效。这可能是通过调节患者胰高血糖素样肽-1(GLP-1)的水平来实现的。
Objective:To investigate the effect of acupoint catgut embedding combined with antidiabetic drugs on the level of glucagon-like peptide-1(GLP-1)in diabetic patients.Methods:74diabetic patients were randomly divided into three groups:antidiabetic drugs combined with acupoint catgut embedding group,acupoint catgut embedding group and antidiabetic drugs group,and the level of glucagon-like peptide-1(GLP-1)was observed.Results:The levels of glucagon-like peptide-1(GLP-1)in the antidiabetic drugs combined with acupoint catgut embedding group has a statistically significant difference before and after treatment(P<0.05),and there were statistically significant differences between the antidiabetic drugs combined with acupoint catgut embedding group,acupoint catgut embedding group and antidiabetic drugs group after treatment(P<0.05).By comparing the levels of GLP-1in the three groups of diabetes patients before and after treatment,the treatment effect was evaluated.The effective rate of the antidiabetic drugs combined with acupoint catgut embedding group was 92.00%,the effective rate of the acupoint catgut embedding group was 66.67%,and the effective rate of the antidiabetic drugs group was 80.00%.The effective rate of the antidiabetic drugs combined with acupoint catgut embedding group was higher than the acupoint catgut embedding group and the antidiabetic drugs group,with statistical significance(P<0.05).Conclusion:Acupoint catgut embedding combined with antidiabetic drugs has significant clinical effect on diabetes.This may be achieved by regulating patients'levels of glucagon-like peptide-1(GLP-1).
作者
张璐
范丹
岳珊
马界
ZHANG Lu;FAN Dan;YUE Shan(Institute of Traditional Chinese Medicine,Sichuan Academy of Chinese Medicine,Chengdu Sichuan 610031,China)
出处
《四川中医》
2024年第1期178-181,共4页
Journal of Sichuan of Traditional Chinese Medicine
基金
四川省科技厅基本科研项目(编号:2020JDKY0031)。
关键词
穴位埋线
降糖药
糖尿病
胰高血糖素样肽-1
acupoint catgut embedding
antidiabetic drugs
diabetes
glucagon-like peptide-1
